Insight Molecular Diagnostics Inc.
USD5.59
+0.17 (+3.14%)
CEO
Joshua Riggs
IPO Date
2015-12-30
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$5.45
Prev. Close
$5.42
Day Low
$5.20
Day High
$5.59
52W Low
$2.33
52W High
$8.51
Market Cap
$0.15B
Volume
0.03M
| -0.5 |
| 31 Dec 2023 | FY | 27.5% | -1848.4% | -135.7% | -37.1% | 0.14 | 1.49 | -0.7 |
| 31 Dec 2022 | FY | -1.9% | -7609.8% | -184.1% | -72.8% | 0.09 | 2.11 | -0.5 |
| 31 Dec 2021 | FY | 64.6% | -2916.2% | -98.3% | -40.2% | 0.09 | 2.77 | -3.0 |
| 31 Dec 2020 | FY | -52.5% | -2461.5% | -89.4% | -54.0% | 0.26 | 1.03 | -5.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -72.4% | -56.0% | 0.20 | 5.17 | -5.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -460.2% | -165.5% | 0.50 | 1.55 | -3.3 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -440.0% | -189.7% | 0.57 | 1.91 | -7.2 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -113.2% | -77.3% | 0.05 | 2.97 | -16.7 |
| -2.5 |
| 30 Sept 2025 | Q3 | 53.5% | -4174.6% | 118.0% | -24.7% | -0.34 | 2.79 | -2.4 |
| 30 Jun 2025 | Q2 | 67.6% | -1880.7% | -887.2% | -19.3% | 3.07 | 4.04 | -2.5 |
| 31 Mar 2025 | Q1 | 62.0% | -312.0% | -65.3% | -11.1% | 0.34 | 3.75 | -2.9 |
| 31 Dec 2024 | Q4 | 40.0% | -2255.1% | 273.0% | -95.5% | -0.30 | 1.62 | -0.3 |
| 30 Sept 2024 | Q3 | 43.5% | -11733.0% | -138.9% | -19.2% | 0.41 | 0.53 | -0.7 |
| 30 Jun 2024 | Q2 | 48.1% | -4355.8% | -20.0% | -6.1% | 0.16 | 1.38 | -2.1 |
| 31 Mar 2024 | Q1 | 25.6% | -5186.9% | -54.0% | -12.9% | 0.20 | 0.78 | -0.7 |
| 31 Dec 2023 | Q4 | -30.3% | -5093.0% | -78.1% | -21.4% | 0.14 | 1.49 | -0.3 |